CSF1R Kinase Inhibitor Pexidartinib Disrupts Bile Acid Homeostasis in Mice

被引：0
|
作者：
Li, Feng [1 ]
Qin, Xuan [2 ]
Chen, Si [3 ]
Zhou, Shenzhi [2 ]
Hakenjos, John M. [2 ]
Guo, Lei [3 ]
Mackenzie, Kevin R. [2 ]
机构：
[1] Baylor Coll Med, Ctr Drug Discovery, Houston, TX USA
[2] Baylor Coll Med, Houston, TX USA
[3] US FDA, Silver Spring, MD USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2025年 / 392卷 / 03期
关键词：
D O I：
10.1016/j.jpet.2025.103409
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
192428
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model
    Tahmasebi, Fatemeh
    Barati, Shirin
    Kashani, Iraj Ragerdi
    NEUROPEPTIDES, 2021, 89
  • [22] Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945
    Nicolau Beckmann
    Elisa Giorgetti
    Anna Neuhaus
    Stefan Zurbruegg
    Nathalie Accart
    Paul Smith
    Julien Perdoux
    Ludovic Perrot
    Mark Nash
    Sandrine Desrayaud
    Peter Wipfli
    Wilfried Frieauff
    Derya R. Shimshek
    Acta Neuropathologica Communications, 6
  • [23] CSF1R mutations in inherited leukodystrophies
    Nature Reviews Neurology, 2013, 9 (7) : 358 - 358
  • [24] Engineering an inhibitor-resistant human CSF1R variant for microglia replacement
    Chadarevian, Jean Paul
    Lombroso, Sonia I.
    Peet, Graham C.
    Hasselmann, Jonathan
    Tu, Christina
    Marzan, Dave E.
    Capocchi, Joia
    Purnell, Freddy S.
    Nemec, Kelsey M.
    Lahian, Alina
    Escobar, Adrian
    England, Whitney
    Chaluvadi, Sai
    O'Brien, Carleigh A.
    Yaqoob, Fazeela
    Aisenberg, William H.
    Porras-Paniagua, Matias
    Bennett, Mariko L.
    Davtyan, Hayk
    Spitale, Robert C.
    Blurton-Jones, Mathew
    Bennett, F. Chris
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 220 (03):
  • [25] Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945
    Beckmann, Nicolau
    Giorgetti, Elisa
    Neuhaus, Anna
    Zurbruegg, Stefan
    Accart, Nathalie
    Smith, Paul
    Perdoux, Julien
    Perrot, Ludovic
    Nash, Mark
    Desrayaud, Sandrine
    Wipfli, Peter
    Frieauff, Wilfried
    Shimshek, Derya R.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6 : 9
  • [26] Preclinical evaluation of sulfatinib, a novel angio-immuno kinase inhibitor targeting VEGFR, FGFR1 and CSF1R kinases
    Zhou, Jinghong
    Ni, Jun
    Cheng, Min
    Yang, Na
    Liang, Junqing
    Ge, Liang
    Zhang, Wei
    Tang, Jianxing
    Sun, Qiaoling
    Li, Fu
    Hu, Jia
    Shi, Dongxia
    Chen, Hongbo
    Long, Jingwen
    Sun, Junen
    Yin, Fang
    Ge, Xuelei
    Jia, Hong
    Zhou, Feng
    Ren, Yongxin
    Qing, Weiguo
    Su, Weiguo
    CANCER RESEARCH, 2017, 77
  • [27] CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
    Mancuso, Renzo
    Fryatt, Gemma
    Cleal, Madeleine
    Obst, Juliane
    Pipi, Elena
    Monzon-Sandoval, Jimena
    Ribe, Elena
    Winchester, Laura
    Webber, Caleb
    Nevado, Alejo
    Jacobs, Tom
    Austin, Nigel
    Theunis, Clara
    Grauwen, Karolien
    Ruiz, Eva Daniela
    Mudher, Amrit
    Vicente-Rodriguez, Marta
    Parker, Christine A.
    Simmons, Camilla
    Cash, Diana
    Richardson, Jill
    Jones, Declan N. C.
    Lovestone, Simon
    Gomez-Nicola, Diego
    Perry, V. Hugh
    Bullmore, Edward T.
    Bhatti, Junaid
    Chamberlain, Samuel J.
    Correia, Marta M.
    Crofts, Anna L.
    Dickinson, Amber
    Foster, Andrew C.
    Kitzbichler, Manfred G.
    Knight, Clare
    Lynall, Mary-Ellen
    Maurice, Christina
    O'Donnell, Ciara
    Pointon, Linda J.
    Hyslop, Peter St George
    Turner, Lorinda
    Vertes, Petra
    Widmer, Barry
    Williams, Guy B.
    Morgan, B. Paul
    Leckey, Claire A.
    Morgan, Angharad R.
    O'Hagan, Caroline
    Touchard, Samuel
    Cavanagh, Jonathan
    Deith, Catherine
    BRAIN, 2019, 142 : 3243 - 3264
  • [28] Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor–loaded nanoparticle enhances anticancer efficacy
    Anujan Ramesh
    Vaishali Malik
    Hayat Anu Ranjani
    Harriet Smith
    Ashish A. Kulkarni
    Drug Delivery and Translational Research, 2021, 11 : 2317 - 2327
  • [29] Camp-Protein Kinase A Inhibits Macrophage Maturation By Dna Hypermethylation Of Csf1r
    Zaslona, Z.
    Scruggs, A. M.
    Peters-Golden, M.
    Huang, S. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [30] CSF1R expression in soft tissue tumors
    West, RB
    Kaygusuz, G
    Subramanian, S
    Corless, CL
    Rubin, BP
    Montgometry, K
    Zhu, SX
    Nielsen, TI
    Patel, R
    Goldblum, JR
    Brown, PO
    MODERN PATHOLOGY, 2005, 18 : 23A - 23A
12345